CALT - Calliditas Therapeutics: Everest Medicines launches Nefecon in China
2024-05-14 08:01:12 ET
More on Calliditas Therapeutics
- Calliditas Therapeutics AB (publ) (CALT) Q4 2023 Earnings Call Transcript
- Calliditas releases phase 2 results on head and neck cancer asset setanaxib
- Seeking Alpha’s Quant Rating on Calliditas Therapeutics
- Historical earnings data for Calliditas Therapeutics
- Financial information for Calliditas Therapeutics